Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yumi Mitsuya

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Interventional Pain Medicine|September 6, 2024
Attempted aspiration of a symptomatic lumbar juxtafacet cyst resulting in improvement of acute onset radiculopathy with progressive motor weaknessSharlene Su, Yumi Mitsuya, Derek Schirmer, et al.
Genome Research|June 30, 2007
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistanceChunlin Wang, Yumi Mitsuya, Baback Gharizadeh, et al.
The Journal of Infectious Diseases|October 24, 2007
Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatmentYumi Mitsuya, Tommy F Liu, Soo-Yon Rhee, et al.
British Journal of Haematology|December 21, 2002
Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MMShima Uneda, Hiroyuki Hata, Fumihiko Matsuno, et al.
British Journal of Haematology|February 13, 2003
A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse modelShima Uneda, Hiroyuki Hata, Fumihiko Matsuno, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibilityVici Varghese, Yumi Mitsuya, Rajin Shahriar, et al.
Plos Computational Biology|April 26, 2008
Viral population estimation using pyrosequencingNicholas Eriksson, Lior Pachter, Yumi Mitsuya, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 26, 2024
Single-level laminoplasty approach to selective dorsal rhizotomy with conus localization by rapid spine MRIJohn P Andrews, Cecilia Dalle Ore, Joseph Falcone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2006
HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mLYumi Mitsuya, Mark A Winters, W Jeffrey Fessel, et al.
AIDS Research and Human Retroviruses|January 11, 2007
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failureYumi Mitsuya, Mark A Winters, W Jeffrey Fessel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Interventional Pain Medicine|September 6, 2024
Attempted aspiration of a symptomatic lumbar juxtafacet cyst resulting in improvement of acute onset radiculopathy with progressive motor weaknessSharlene Su, Yumi Mitsuya, Derek Schirmer, et al.
Genome Research|June 30, 2007
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistanceChunlin Wang, Yumi Mitsuya, Baback Gharizadeh, et al.
The Journal of Infectious Diseases|October 24, 2007
Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatmentYumi Mitsuya, Tommy F Liu, Soo-Yon Rhee, et al.
British Journal of Haematology|December 21, 2002
Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MMShima Uneda, Hiroyuki Hata, Fumihiko Matsuno, et al.
British Journal of Haematology|February 13, 2003
A nitric oxide synthase inhibitor, N(G)-nitro-l-arginine-methyl-ester, exerts potent antiangiogenic effects on plasmacytoma in a newly established multiple myeloma severe combined immunodeficient mouse modelShima Uneda, Hiroyuki Hata, Fumihiko Matsuno, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibilityVici Varghese, Yumi Mitsuya, Rajin Shahriar, et al.
Plos Computational Biology|April 26, 2008
Viral population estimation using pyrosequencingNicholas Eriksson, Lior Pachter, Yumi Mitsuya, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 26, 2024
Single-level laminoplasty approach to selective dorsal rhizotomy with conus localization by rapid spine MRIJohn P Andrews, Cecilia Dalle Ore, Joseph Falcone, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2006
HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mLYumi Mitsuya, Mark A Winters, W Jeffrey Fessel, et al.
AIDS Research and Human Retroviruses|January 11, 2007
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failureYumi Mitsuya, Mark A Winters, W Jeffrey Fessel, et al.
Pageof 2